New Generation of Medical Research | Hialeah, FL

Research site

(Unclaimed)

Location

7600 West 20th Avenue Suite 103, Hialeah, Florida, United States of America

Site insights

Top conditions

Top treatments

Obicetrapib

NT-0796

INS068

Ziltivekimab

AT-001

HU6

Allopurinol

CK-4021586

IW-1973

IONIS-AGT-LRx

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 14 total trials

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation (HERMES)

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will either get z...

Enrolling

Heart Failure

Drug: Placebo

Drug: Ziltivekimab

A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis (KATALYST-AV)

The purpose of this study is to evaluate if ataciguat slows the progression of moderate calcific aortic valve stenosis in adults.

Enrolling

Moderate Aortic Valve Stenosis

Drug: Placebo

Drug: Ataciguat

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.

Enrolling

Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)

Drug: CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)

Drug: Placebo to match CK-4021586

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease (PREVAIL)

This study will be a placebo-controlled, double-blind, randomized, phase 3 study in participants with Atherosclerotic Cardiovascular Disease (ASCVD)...

Active, not recruiting

Atherosclerotic Cardiovascular Disease

Drug: Obicetrapib

Drug: Placebo

Locations recently updated

Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus

A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet...

Enrolling

Obesity and Type 2 Diabetes

Drug: NT-0796

Drug: Placebo

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diab...

Active, not recruiting

Diabetic Cardiomyopathies

Drug: AT-001

Drug: Placebo